At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PBM Psyence Biomedical Ltd
Market Closed 12-05 16:00:00 EST
1.76
-0.05
-2.76%
盘后1.77
+0.01+0.57%
19:50 EST
High1.85Low1.76Vol61.88K
Open1.81D1 Closing1.81Amplitude4.97%
Mkt Cap3.29MTradable Cap3.27MTotal Shares1.87M
T/O110.86KT/O Rate3.33%Tradable Shares1.86M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Psyence BioMed Launches Psilocybin Longevity Research Program
Reuters  ·  11-25
Psyence BioMed Launches Psilocybin Longevity Research Program
Psyence BioMed Takes Minority Stake in PsyLabs to Boost African Ibogaine Operations
Reuters  ·  11-22
Psyence BioMed Takes Minority Stake in PsyLabs to Boost African Ibogaine Operations
WellsCare Partners with SolnanoMed to Launch IASO and IASO Ultra in Thailand
prnewswire  ·  11-17
WellsCare Partners with SolnanoMed to Launch IASO and IASO Ultra in Thailand
Psyence BioMed Invests in PsyLabs to Establish Ibogaine Operations in Africa
Reuters  ·  11-12
Psyence BioMed Invests in PsyLabs to Establish Ibogaine Operations in Africa
Psyence Biomed Establishes Ibogaine Operations in Africa Through Strategic Investment in Psylabs
THOMSON REUTERS  ·  11-12
Psyence Biomed Establishes Ibogaine Operations in Africa Through Strategic Investment in Psylabs
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
Benzinga_recent_news  ·  11-12
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
Psyence BioMed Doses Multiple Patients in Phase IIb Psilocybin Trial for Adjustment Disorder
Reuters  ·  11-06
Psyence BioMed Doses Multiple Patients in Phase IIb Psilocybin Trial for Adjustment Disorder
Psyence Biomed Doses Multiple Patients and Expands Clinical Sites in Phase Iib Study for Adjustment Disorder in Palliative Care
THOMSON REUTERS  ·  11-06
Psyence Biomed Doses Multiple Patients and Expands Clinical Sites in Phase Iib Study for Adjustment Disorder in Palliative Care
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Benzinga  ·  11-05
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Psyence BioMed Invests $3.5 Million in PsyLabs
Reuters  ·  11-03
Psyence BioMed Invests $3.5 Million in PsyLabs
Psyence Biomed Strengthens Strategic Partnership With Psylabs Through USD $3,500,000 Follow-on Investment
THOMSON REUTERS  ·  11-03
Psyence Biomed Strengthens Strategic Partnership With Psylabs Through USD $3,500,000 Follow-on Investment
The Pharmacy Stock That's Cheaper Than It Should Be
Motley Fool  ·  10-15
The Pharmacy Stock That's Cheaper Than It Should Be
BRIEF-Psyence Biomedical's chairman, Jody Aufrichtig, assumes role Of CEO
Reuters  ·  10-10
BRIEF-Psyence Biomedical's chairman, Jody Aufrichtig, assumes role Of CEO
Psyence Biomedical Ltd: Neil Maresky Has Transitioned From His Role as CEO and Director to Serve as Co’s Global Head, Clinical Development
THOMSON REUTERS  ·  10-10
Psyence Biomedical Ltd: Neil Maresky Has Transitioned From His Role as CEO and Director to Serve as Co’s Global Head, Clinical Development
Psyence Biomedical Ltd: Co’s Chairman, Jody Aufrichtig, Has Assumed Role of CEO
THOMSON REUTERS  ·  10-10
Psyence Biomedical Ltd: Co’s Chairman, Jody Aufrichtig, Has Assumed Role of CEO
Psyence Biomedical names Jody Aufrichtig as CEO as Neil Maresky transitions to lead clinical development
Reuters  ·  10-10
Psyence Biomedical names Jody Aufrichtig as CEO as Neil Maresky transitions to lead clinical development
Masverse and Lembaga Zakat Selangor Pioneer Blockchain-Based Zakat Distribution through e-Wakalah Proof-of-Concept
prnewswire  ·  10-09
Masverse and Lembaga Zakat Selangor Pioneer Blockchain-Based Zakat Distribution through e-Wakalah Proof-of-Concept
Psyence Biomedical: Files Prospectus Relates to Potential Offer, Resale, From Time to Time 50 Mln Common Shares by White Lion Capital, Llc
THOMSON REUTERS  ·  10-07
Psyence Biomedical: Files Prospectus Relates to Potential Offer, Resale, From Time to Time 50 Mln Common Shares by White Lion Capital, Llc
Psyence Group Inc. Signs Letter of Intent to Acquire GoldCoast Resource Corp., Advances $250,000 Secured Loan for Exploration Preparation
Reuters  ·  10-06
Psyence Group Inc. Signs Letter of Intent to Acquire GoldCoast Resource Corp., Advances $250,000 Secured Loan for Exploration Preparation
EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions
Benzinga_recent_news  ·  10-01
EXCLUSIVE: Scienture Secures Hypertension Drug Purchase Agreements With 2,500 Healthcare Institutions

Introduction

Company Name.
Psyence Biomedical Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.
Issue price:
--